Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Dravet Syndrome
.
Show all posts
Showing posts with label
Dravet Syndrome
.
Show all posts
Wednesday, March 6, 2019
Zogenix Submits New Drug Application to U.S. Food & Drug Administration for Fintepla for the Treatment of Dravet Syndrome
›
Zogenix, Inc. (NASDAQ:ZGNX), a global pharmaceutical company developing rare disease therapies, announced it has completed it...
›
Home
View web version